|
 | Up a level |
Gabriel, Nishanth and Hareendran, Sangeetha and Sen, Dwaipayan and Gadkari, Rupali A and Sudha, Govindarajan and Selot, Ruchita and Hussain, Mansoor and Dhaksnamoorthy, Ramya and Samuel, Rekha and Srinivasan, Narayanaswamy and Srivastava, Alok and Jayandharan, Giridhara R (2013) Bioengineering of AAV2 Capsid at Specific Serine, Threonine, or Lysine Residues Improves Its Transduction Efficiency in Vitro and in Vivo. In: HUMAN GENE THERAPY METHODS, 24 (2). 80-U117.
Sen, Dwaipayan and Gadkari, Rupali A and Sudha, Govindarajan and Gabriel, Nishanth and Kumar, Yesupatham Sathish and Selot, Ruchita and Samuel, Rekha and Rajalingam, Sumathi and Ramya, V and Nair, Sukesh C and Srinivasan, Narayanaswamy and Srivastava, Alok and Jayandharan, Giridhara R (2013) Targeted Modifications in Adeno-Associated Virus Serotype 8 Capsid Improves Its Hepatic Gene Transfer Efficiency In Vivo. In: HUMAN GENE THERAPY METHODS, 24 (2). 104-U64.
Sen, Dwaipayan and Gadkari, Rupali A and Sudha, Govindarajan and Gabriel, Nishanth and Ramya, V and Nair, Sukesh C and Srinivasan, N and Srivastava, Alok and Jayandharan, Giridhara R (2013) A novel adeno-associated virus serotype (AAV)-8 capsid mutant improves human coagulation factor IX expression in vivo. In: Molecular Therapy, 21 (1). S47-S47.
Sen, Dwaipayan and Kalaivani, V and Gadkari, Rupali and Sudha, G and Srinivasan, N and Srivastava, Alok and Jayandharan, Giridhara R (2013) Multiple molecular alterations in phosphodegrons 1-3 within AAV2 capsid demonstrates higher hepatic gene transfer efficiency. In: Molecular Therapy, 21 (1). S206-S207.
Hareendran, Sangeetha and Hussain, Mansoor and Sen, Dwaipayan and Balakrishnan, Balaji and SathishKumar, Yesupatham and Kalaivani, Vaani and Ramakrishna, Banumathi and Srivastava, Arun and Srivastava, Alok and Jayandharan, Giridhara Rao (2012) Bio-Engineering of Adeno-Associated Virus Serotype (AAV)-2 Capsid at Serine/Threonine Residues Improves Its Transduction Efficiency Both In Vitro and In Vivo. In: Molecular Therapy, 20 (1).
